Insulet

Insulet(PODD)

ACTON, MA
Biotechnology10 H-1B visas (FY2023)
WebsiteLinkedInCareers Page

Focus: Insulin Pump

Insulet is a life sciences company focused on Insulin Pump.

Metabolic Diseases
Funding Stage
PUBLIC
Employees
201-500
Open Jobs
0

Pipeline & Clinical Trials

Omnipod 5
Diabetes
N/A
Clinical Trials (1)
NCT07039942French Prospective Multicentric Study in Real World
N/A
Omnipod 5 Automated Insulin Delivery System
Type 2 Diabetes Mellitus
N/A
Clinical Trials (1)
NCT04617795Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes
N/A
Omnipod M system
Type 2 Diabetes Mellitus
N/A
Clinical Trials (1)
NCT07276776An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes
N/A
Omnipod Horizon™ Automated Glucose Control System
Type 1 Diabetes Mellitus
N/A
Clinical Trials (1)
NCT04176731Prepivotal Omnipod Horizon™ Automated Glucose Control System
N/A
Heart rate informed SSM+HMM
Type 1 Diabetes Mellitus
N/A
Insulet automated glucose control system
Type1 Diabetes Mellitus
N/A
Clinical Trials (1)
NCT03216460Insulet Artificial Pancreas Free-Living IDE3
N/A
N/A
Clinical Trials (1)
NCT03064906Insulet Artificial Pancreas Evaluating Meal Performance and Moderate Exercise (IDE2)
N/A
Omnipod Horizon™ Automated Glucose Control System
Type 1 Diabetes Mellitus
N/A
Clinical Trials (1)
NCT04196140Pivotal Omnipod Horizon™ Automated Glucose Control System
N/A
N/A
Clinical Trials (1)
NCT06144554Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
N/A
Omnipod 5
Diabetes
N/A
Clinical Trials (1)
NCT07317102Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)
N/A
Insulet Artificial Pancreas
Type 1 Diabetes
N/A
Clinical Trials (1)
NCT02897557Insulet Artificial Pancreas Early Feasibility Study
N/A
Omnipod Horizon™ Automated Glucose Control System
Type 1 Diabetes Mellitus
N/A
Clinical Trials (1)
NCT04476472Omnipod Horizon™ Automated Glucose Control System Preschool Cohort
N/A
N/A
Clinical Trials (1)
NCT04226378Canadian Real-World Outcomes of Omnipod Initiation in People With T1D
N/A
The Omnipod 5/Horizon HCL system
Diabetes Mellitus
N/A
Clinical Trials (1)
NCT04714216Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility
N/A
French National Cohort of People With Type 1 Diabetes
Diabetes Mellitus, Type 1
N/A
Omnipod 5 SmartAdjust 2.0 System
Diabetes Mellitus, Type 1, Type 2
N/A
Clinical Trials (1)
NCT06865989Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 Diabetes
N/A
N/A
Clinical Trials (1)
NCT05923827Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults
N/A
Omnipod 5 SA2.0 System
Diabetes Mellitus
N/A
Clinical Trials (1)
NCT06547918SmartAdjust 2.0 System With Type 1 and Type 2 Diabetes
N/A
Omnipod M system
Diabetes Mellitus
N/A
Clinical Trials (1)
NCT07039981Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Adults With Type 2 Diabetes
N/A
Exercise strategies
Type 1 Diabetes
N/A
Clinical Trials (1)
NCT04383015Carbohydrate and Insulin Requirements During Prolonged Fasted Exercise
N/A
Closed Loop Control
Type 1 Diabetes Mellitus
N/A
N/A
Active Comparator: Omnipod M System with lower starting dose
Type 2 Diabetes Mellitus
N/A
Clinical Trials (1)
NCT07070830Simplified Onboarding in Adults With Type 2 Diabetes
N/A
Omnipod 5 Automated Glucose Control System
Diabetes Mellitus
N/A
Clinical Trials (1)
NCT06181721Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
N/A
Omnipod Horizon™ Automated Glucose Control System
Type 1 Diabetes
N/A
Clinical Trials (1)
NCT04320069Continuous Glucose Monitoring System (CGM)-Informed Bolus Calculator Study
N/A
Omnipod 5 System
Type 1 Diabetes
N/A
Clinical Trials (1)
NCT05409131Omnipod 5 System Compared to Pump Therapy
N/A
Omnipod 5 Automated Glucose Control System
Type2 Diabetes
N/A
Clinical Trials (1)
NCT05815342OP5-005 Using Omnipod 5 in Adults With Type 2
N/A
N/A
Human regular U-500 insulin
Type 2 Diabetes Mellitus
Phase 3

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 2009
Portfolio: 23 clinical trials
H-1B (2023): 10 approvals
SEC Filings: 2 available

Financials (FY2025)

Revenue
$1.7B30%
R&D Spend
$205M(12%)14%
Net Income
$206M
Source: SEC 10-K Filing

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
10
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub